Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 244

1.

A Randomized Comparison of Anthropomorphic Changes With Preferred and Alternative Efavirenz-Based Antiretroviral Regimens in Diverse Multinational Settings.

Erlandson KM, Taejaroenkul S, Smeaton L, Gupta A, Singini IL, Lama JR, Mngqibisa R, Firnhaber C, Cardoso SW, Kanyama C, Machado da Silva AL, Hakim JG, Kumarasamy N, Campbell TB, Hughes MD.

Open Forum Infect Dis. 2015 Jun 24;2(3):ofv095. doi: 10.1093/ofid/ofv095. eCollection 2015 Sep.

PMID:
26213694
2.

Phenotype, Genotype and Drug Resistance in Subtype C HIV-1 Infection.

Derache A, Wallis CL, Vardhanabhuti S, Bartlett J, Kumarasamy N, Katzenstein D.

J Infect Dis. 2015 Jul 14. pii: jiv383. [Epub ahead of print]

PMID:
26175454
3.

Virological efficacy with first-line antiretroviral treatment in India: predictors of viral failure and evidence of viral resuppression.

Shet A, Neogi U, Kumarasamy N, DeCosta A, Shastri S, Rewari BB.

Trop Med Int Health. 2015 Jul 3. doi: 10.1111/tmi.12563. [Epub ahead of print]

PMID:
26146863
4.

Tenofovir-based antiretroviral therapy in HBV-HIV coinfection: results from the TREAT Asia HIV Observational Database.

Boettiger DC, Kerr S, Ditangco R, Chaiwarith R, Li PC, Merati TP, Pham TT, Kiertiburanakul S, Kumarasamy N, Vonthanak S, Lee CK, Van Kinh N, Pujari S, Wong WW, Kamarulzaman A, Zhang F, Yunihastuti E, Choi JY, Oka S, Ng OT, Kantipong P, Mustafa M, Ratanasuwan W, Durier N, Law M; TREAT Asia HIV Observational Database.

Antivir Ther. 2015 Jun 12. doi: 10.3851/IMP2972. [Epub ahead of print]

PMID:
26069150
5.

Pre-cART Elevation of CRP and CD4+ T-cell Immune Activation Associated with HIV Clinical Progression in a Multinational Case-Cohort Study.

Balagopal A, Asmuth DM, Yang WT, Campbell TB, Gupte N, Smeaton L, Kanyama C, Grinsztejn B, Santos B, Supparatpinyo K, Badal-Faesen S, Lama JR, Lalloo UG, Zulu F, Pawar JS, Riviere C, Kumarasamy N, Hakim J, Li XD, Pollard RB, Semba RD, Thomas DL, Bollinger RC, Gupta A; ACTG PEARLS and NWCS 319 Study team.

J Acquir Immune Defic Syndr. 2015 May 21. [Epub ahead of print]

PMID:
26017661
6.

Adherence to Early Antiretroviral Therapy: Results From HPTN 052, a Phase III, Multinational Randomized Trial of ART to Prevent HIV-1 Sexual Transmission in Serodiscordant Couples.

Safren SA, Mayer KH, Ou SS, McCauley M, Grinsztejn B, Hosseinipour MC, Kumarasamy N, Gamble T, Hoffman I, Celentano D, Chen YQ, Cohen MS; HPTN 052 Study Team.

J Acquir Immune Defic Syndr. 2015 Jun 1;69(2):234-40. doi: 10.1097/QAI.0000000000000593.

PMID:
26009832
7.

Prevalence and concordance of human papillomavirus infection at multiple anatomic sites among HIV-infected women from Chennai, India.

Menezes LJ, Poongulali S, Tommasino M, Lin HY, Kumarasamy N, Fisher KJ, Saravanan S, Gheit T, Ezhilarasi C, Jeeva A, Lu B, Giuliano AR.

Int J STD AIDS. 2015 May 22. pii: 0956462415587226. [Epub ahead of print]

PMID:
26002318
8.

Differences in antiretroviral safety and efficacy by sex in a multinational randomized clinical trial.

Firnhaber C, Smeaton LM, Grinsztejn B, Lalloo U, Faesen S, Samaneka W, Infante R, Rana A, Kumarasamy N, Hakim J, Campbell TB.

HIV Clin Trials. 2015 May-Jun;16(3):89-99. doi: 10.1179/1528433614Z.0000000013. Epub 2015 May 15.

PMID:
25979186
9.

Prevalence and incidence of liver dysfunction and assessment of biomarkers of liver disease in HIV-infected Asian children.

Aurpibul L, Bunupuradah T, Sophan S, Boettiger D, Wati DK, Nguyen LV, Saphonn V, Hansudewechakul R, Chokephaibulkit K, Lumbiganon P, Truong KH, Do VC, Kumarasamy N, Yusoff NK, Razali K, Kurniati N, Fong SM, Nallusamy R, Sohn AH; TREAT Asia Pediatric HIV Observational Database.

Pediatr Infect Dis J. 2015 Jun;34(6):e153-8. doi: 10.1097/INF.0000000000000693.

PMID:
25970117
10.

Implementation and Operational Research: Effects of CD4 Monitoring Frequency on Clinical End Points in Clinically Stable HIV-Infected Patients With Viral Suppression.

Ahn JY, Boettiger D, Law M, Kumarasamy N, Yunihastuti E, Chaiwarith R, Lee MP, Sim BL, Oka S, Wong W, Kamarulzaman A, Kantipong P, Phanuphak P, Ng OT, Kiertiburanakul S, Zhang F, Pujari S, Ditangco R, Ratanasuwan W, Merati TP, Saphonn V, Sohn AH, Choi JY; TREAT Asia HIV Observational Databases (TAHOD).

J Acquir Immune Defic Syndr. 2015 Jul 1;69(3):e85-92. doi: 10.1097/QAI.0000000000000634.

PMID:
25850606
11.

Differences in Evolution of HIV-1 Subtype C Reverse Transcriptase Between Children and Adults Likely Explained by Maturity of Cytotoxic T-Lymphocyte Responses.

Saravanan S, Gomathi S, Kausalya B, Boobalan J, Murugavel KG, Balakrishnan P, Mothi SN, Solomon SS, Kumarasamy N, Selvamuthu P, Solomon S, Smith DM.

AIDS Res Hum Retroviruses. 2015 Jun;31(6):655-7. doi: 10.1089/AID.2015.0023. Epub 2015 Apr 28.

PMID:
25839730
12.

Treatment of W. bancrofti (Wb) in HIV/Wb coinfections in South India.

Talaat KR, Babu S, Menon P, Kumarasamy N, Sharma J, Arumugam J, Dhakshinamurthy K, Srinivasan R, Poongulali S, Gu W, Fay MP, Swaminathan S, Nutman TB.

PLoS Negl Trop Dis. 2015 Mar 20;9(3):e0003622. doi: 10.1371/journal.pntd.0003622. eCollection 2015 Mar.

13.

Impact of Gender on Long-Term Treatment Outcomes of Highly Active Antiretroviral Therapy (HAART) in the TREAT Asia HIV Observational Database.

Lee MP, Zhou J, Messerschmidt L, Honda M, Ditangco R, Sirisanthana T, Kumarasamy N, Phanuphak P, Chen YM, Zhang F, Saphonn V, Kiertiburanakul S, Lee CK, Pujari S, Choi JY, Kamarulzaman A, Yunihastuti E, Merati TP, Lim PL, Li PC; TREAT Asia HIV Observational Database.

AIDS Patient Care STDS. 2015 May;29(5):229-31. doi: 10.1089/apc.2014.0232. Epub 2015 Mar 16. No abstract available.

PMID:
25774867
14.

Long term impact of antiretroviral therapy--can we end HIV epidemic, the goal beyond 2015.

Kumarasamy N, Pendse R.

Indian J Med Res. 2014 Dec;140(6):701-3. No abstract available.

15.

Raltegravir non-inferior to nucleoside based regimens in second-line therapy with lopinavir/ritonavir over 96 weeks: a randomised open label study for the treatment of HIV-1 infection.

Amin J, Boyd MA, Kumarasamy N, Moore CL, Losso MH, Nwizu CA, Mohapi L, Kerr SJ, Sohn AH, Teppler H, Renjifo B, Molina JM, Emery S, Cooper DA.

PLoS One. 2015 Feb 27;10(2):e0118228. doi: 10.1371/journal.pone.0118228. eCollection 2015.

16.

Safety and efficacy of darunavir/ritonavir in treatment-experienced pediatric patients: week 48 results of the ARIEL trial.

Violari A, Bologna R, Kumarasamy N, Pilotto JH, Hendrickx A, Kakuda TN, Lathouwers E, Opsomer M, Van de Casteele T, Tomaka FL.

Pediatr Infect Dis J. 2015 May;34(5):e132-7. doi: 10.1097/INF.0000000000000644.

PMID:
25719453
17.

C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settings.

Tenforde MW, Gupte N, Dowdy DW, Asmuth DM, Balagopal A, Pollard RB, Sugandhavesa P, Lama JR, Pillay S, Cardoso SW, Pawar J, Santos B, Riviere C, Mwelase N, Kanyama C, Kumwenda J, Hakim JG, Kumarasamy N, Bollinger R, Semba RD, Campbell TB, Gupta A; ACTG PEARLS and NWCS 319 Study Group.

PLoS One. 2015 Feb 26;10(2):e0117424. doi: 10.1371/journal.pone.0117424. eCollection 2015.

18.

Lopinavir/Ritonavir Monotherapy as Second-line Antiretroviral Treatment in Resource-Limited Settings: Week 104 Analysis of AIDS Clinical Trials Group (ACTG) A5230.

Kumarasamy N, Aga E, Ribaudo HJ, Wallis CL, Katzenstein DA, Stevens WS, Norton MR, Klingman KL, Hosseinipour MC, Crump JA, Supparatpinyo K, Badal-Faesen S, Bartlett JA.

Clin Infect Dis. 2015 May 15;60(10):1552-8. doi: 10.1093/cid/civ109. Epub 2015 Feb 18.

PMID:
25694653
19.

Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial.

Kantor R, Smeaton L, Vardhanabhuti S, Hudelson SE, Wallis CL, Tripathy S, Morgado MG, Saravanan S, Balakrishnan P, Reitsma M, Hart S, Mellors JW, Halvas E, Grinsztejn B, Hosseinipour MC, Kumwenda J, La Rosa A, Lalloo UG, Lama JR, Rassool M, Santos BR, Supparatpinyo K, Hakim J, Flanigan T, Kumarasamy N, Campbell TB, Eshleman SH; AIDS Clinical Trials Group (ACTG) A5175 Study Team.

Clin Infect Dis. 2015 May 15;60(10):1541-9. doi: 10.1093/cid/civ102. Epub 2015 Feb 13.

PMID:
25681380
20.

The future role of CD4 cell count for monitoring antiretroviral therapy.

Ford N, Meintjes G, Pozniak A, Bygrave H, Hill A, Peter T, Davies MA, Grinsztejn B, Calmy A, Kumarasamy N, Phanuphak P, deBeaudrap P, Vitoria M, Doherty M, Stevens W, Siberry GK.

Lancet Infect Dis. 2015 Feb;15(2):241-7. doi: 10.1016/S1473-3099(14)70896-5. Epub 2014 Nov 19. Review.

PMID:
25467647
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk